Rongrong Huang

ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer

C. Morrissey, I. Garraway, E. Mostaghel, 2023, bioRxiv.

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.

A. Petcherski, A. Zoubeidi, H. Christofk, 2023, Cell reports.

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

C. Morrissey, I. Garraway, E. Mostaghel, 2024, Nucleic acids research.